InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Baird William D III, Chief Financial Officer. Officer active across 3 companies, notably bluebird bio, Inc.. In total, 26 filings have been recorded. Breakdown: 0 buy · 14 sells. Total volume traded: €510k. History available since 2 August 2021. The latest transaction was disclosed on 17 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Baird William D III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
1,002,825 sharesCommon StockSEC:0001562180-25-003879:0
5,092 shares@ US$4.9454.4% of flowCommon StockSEC:0001562180-25-002603:0
264,000 shares0Common StockSEC:0001562180-25-000278:0
31,718 shares@ US$2.935917.1% of flowCommon StockSEC:0001562180-25-000243:0
763 shares@ US$2.77850.4% of flowCommon StockSEC:0001562180-25-000243:1
586,022 shares0Common StockSEC:0001562180-24-005597:0
56,250 shares0Common StockSEC:0001562180-24-003289:0
91,000 shares0Common StockSEC:0001562180-24-000366:1
1,380 shares@ US$3.75360.9% of flowCommon StockSEC:0001562180-24-000366:0
33,651 shares@ US$3.868522.5% of flowCommon StockSEC:0001562180-24-000303:0
7,031 shares@ US$5.48656.7% of flowCommon StockSEC:0001562180-23-006558:0
6,906 shares@ US$6.12577.3% of flowCommon StockSEC:0001562180-23-006220:0
637 shares@ US$12.861.5% of flowCommon StockSEC:0001562180-23-001427:0
25,000 shares0Common StockSEC:0001562180-23-000951:0
1,077 shares@ US$10.62812.0% of flowCommon StockSEC:0001562180-23-000482:0
3,222 shares@ US$10.33475.9% of flowCommon StockSEC:0001562180-23-000356:0
4,152 shares@ US$16.232512.4% of flowCommon StockSEC:0001562180-22-005951:0
4,080 shares@ US$13.809910.6% of flowCommon StockSEC:0001562180-22-005711:0
33,750 shares0Common StockSEC:0001562180-22-003845:0
427 shares@ US$14.781.1% of flowCommon StockSEC:0001562180-22-001678:0
896 shares@ US$23.90783.7% of flowCommon StockSEC:0001562180-22-000411:0
7,384 shares0Common StockSEC:0001628280-21-023645:0
2,461 shares0Common StockSEC:0001628280-21-023465:0
33,585 shares0Common StockSEC:0001562180-21-005174:0
50,000 sharesCommon stockSEC:0001209191-16-089786:0
25 of 26 declarations
About Baird William D III
Baird William D III is Chief Financial Officer and has 26 filings in total. Across the 26 sampled recent filings, the activity is sell-side, with no reported purchases and 509841 EUR of sales between 2016-01-06 and 2025-05-15. The recent filings relate to 2seventy bio, Inc., bluebird bio, Inc. and AMICUS THERAPEUTICS INC, and the main reported sales are 118974.3936293977 EUR on 2024-01-05, 90688.56371062718 EUR on 2025-01-07, 65767.66972199638 EUR on 2022-08-08, 56200.14804859565 EUR on 2022-07-19, 38628.27731023482 EUR on 2023-08-07, and 35564.37192909666 EUR on 2023-08-24, all at 2seventy bio, Inc.
